5 March 2021 - Italy and the European Union have blocked a shipment of the Oxford-AstraZeneca coronavirus vaccine destined for Australia ...
2 March 2021 - Openness and transparency are key to building confidence in COVID-19 vaccines. Today, EMA and Health Canada ...
2 March 2021 - The Government is following through on an election promise to conduct an independent review into PHARMAC, ...
25 February 2021 - Submission for entering the world’s largest US marketplace. ...
2 March 2021 - Medicines New Zealand is supportive of the proposed review into PHARMAC if it is intended to improve ...
1 March 2021 - Apollo Endosurgery announced today that it has received a breakthrough device designation from the U.S. FDA for ...
1 March 2021 - Patented dynamic cage technology designed to predictably remove wall-adherent clot in peripheral veins, such as deep ...
1 March 2021 - Agios Pharmaceuticals today announced that it has submitted a Supplemental new drug application to the U.S. FDA ...
1 March 2021 - Vazalore is the first ever liquid-filled aspirin capsule with an innovative delivery platform indicated as a pain ...
1 March 2021 - Vascular Grafts Solutions announced today receipt of marketing clearance from the FDA for the VIOLA, a new ...
1 March 2021 - Application for orally administered selective P2X3 receptor antagonist based on findings from two Phase 3 trials in ...
1 March 2021 - FT218 assigned PDUFA target action date of 15 October 2021. ...
1 March 2021 - CorMedix announced today that the US FDA cannot approve the new drug application for DefenCath (taurolidine/heparin catheter ...
1 March 2021 - Athenex today announced that the U.S. FDA has issued a complete response letter for the company’s ...
1 March 2021 - Rare Disease Day is a time to reflect on both the progress that has been made, and ...
1 March 2021 - In addition, LFB announces the online publication of the exploratory in vitro study results on eptacog beta ...